The Alaw Cancer Treatment Unit in Ysbyty Gwynedd is set to undergo a major expansion thanks to charitable support from the Gwynedd Haematology & Cancer Relief Fund.
Details of the expansion were revealed on Tuesday (14th October) at a special celebration event to thank the Fund’s committee for their long term support of the Alaw Unit.
Building work on the £1.2 million project will begin in 2016. The development is being funded exclusively through charitable support, with the Gwynedd Haematology & Cancer Relief Fund pledging £500,000 to support the build. The remaining funding will come from donations through the North Wales NHS Charity Awyr Las, the Alaw Fundraising Group, and other supporters of the Unit.
The development will double the current number of consultation rooms on the Unit and increase the Day Unit’s capacity by 40%. An increase in specialist treatment areas will in the future enable some patients from North West Wales who currently have to travel to England for treatment to receive their treatment on the Alaw Unit.
The existing Alaw Unit was opened in 2000 after a public appeal, which was led by the founding members of the Gwynedd Haematology and Cancer Relief Fund, raised £1.2 million pounds. Since then, the number of patients receiving treatment on the Unit has doubled.
“The demands on the Alaw Unit are increasing by as much as 20% every year because of an increase in the number of people being diagnosed with cancer, and patients being treated for and living longer with the disease,” explained Cancer Services Chief of Staff Sharon Thomas.
“Patients who receive treatment on the Alaw Unit have some of the most positive patient satisfaction scores in Wales, but there is an urgent need to update and expand the Unit to enable us to deliver excellent standards of care for an ever increasing number of patients. The new development will enable us to deliver the very best care that the people of North West Wales deserve.”
Speaking at a special event in Ysbyty Gwynedd, Gwynedd Haematology & Cancer Relief Fund Chairman Dr Huw Parry said:
“It’s entirely fitting that the The Gwynedd Haematology & Cancer Relief Fund, which provided the funding which helped establish the original Alaw Unit will play such an important role in enabling the Unit to expand.”
Kirsty Thomson from Awyr Las added:
“The Alaw Unit is held in extremely high esteem by the ever increasing number of patients that receive treatment there. Without charitable support, this important expansion of the Unit simply couldn’t happen.”